PubMed=7696411; DOI=10.1292/jvms.56.1167
Kadosawa T., Nozaki K., Sasaki N., Takeuchi A.
Establishment and characterization of a new cell line from a canine osteosarcoma.
J. Vet. Med. Sci. 56:1167-1169(1994)

PubMed=23758893; DOI=10.1186/1746-6148-9-116
Milovancev M., Hilgart-Martiszus I.F., McNamara M.J., Goodall C.P., Seguin B., Bracha S., Wickramasekara S.I.
Comparative analysis of the surface exposed proteome of two canine osteosarcoma cell lines and normal canine osteoblasts.
BMC Vet. Res. 9:116.1-116.10(2013)

PubMed=28283079; DOI=10.1016/j.tvjl.2017.02.001
Yoshitake R., Saeki K., Watanabe M., Nakaoka N., Ong S.M., Hanafusa M., Choisunirachon N., Fujita N., Nishimura R., Nakagawa T.
Molecular investigation of the direct anti-tumour effects of nonsteroidal anti-inflammatory drugs in a panel of canine cancer cell lines.
Vet. J. 221:38-47(2017)

PubMed=31959767; DOI=10.1038/s41598-019-56878-x
Song Z.-F., Pearce M.C., Jiang Y., Yang L.-P., Goodall C.P., Miranda C.L., Milovancev M., Bracha S., Kolluri S.K., Maier C.S.
Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities.
Sci. Rep. 10:727-727(2020)

PubMed=33446089; DOI=10.1177/1040638720985242
Ayers J., Milner R.J., Cortes-Hinojosa G., Riva A., Axiak-Bechtel S.M., Sahay B., Cascio M., Lejeune A., Shiomitsu K., Souza C., Hernandez O., Salute M.E.
Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines.
J. Vet. Diagn. Invest. 33:261-278(2021)